Understanding Cancer Clinical Trials: A Patient Guide
What clinical trials are, why they matter, and how to decide if one is right for you
Key Points
- Clinical trials are not a last resort — they offer access to cutting-edge treatments not otherwise available.
- Every cancer treatment in use today was first tested in clinical trials; participation advances care for future patients.
- Patients have the right to ask questions, take time to decide, and withdraw from a trial at any time without penalty.
- Health insurers are required to cover routine costs of care in qualifying clinical trials under the Affordable Care Act.
- The four phases of trials test progressively larger questions: safety (I), efficacy signal (II), definitive comparison (III), and post-approval surveillance (IV).
- Your oncology team, ClinicalTrials.gov, and NCI-designated cancer centers are the best resources for finding appropriate trials.
What Is a Clinical Trial?
Clinical trials are carefully designed and conducted research studies that test new medical treatments, combinations, diagnostic tests, prevention strategies, or supportive care interventions in human volunteers. Every FDA-approved cancer treatment currently in use — every chemotherapy drug, targeted therapy, immunotherapy, and supportive care agent — reached patients through the clinical trial system. Clinical trials are not a last resort or a sign that standard treatments have failed. Many trials enroll patients with newly diagnosed cancers, offering access to investigational therapies…
The Four Phases of Clinical Trials
Clinical trials progress through defined phases, each answering progressively larger questions: Phase I trials are the first step in testing a new treatment in humans. They are primarily designed to evaluate safety, determine the optimal dose, and characterize the pharmacokinetics and pharmacodynamics of the investigational agent. Phase I trials are small, typically enrolling 15–30 patients, and historically enrolled heavily pretreated patients for whom standard options had been exhausted. Modern Phase I trials increasingly use biomarker-selected enrollment, and meaningful tumor responses…
Informed Consent and Patient Rights
Informed consent is the cornerstone of ethical clinical trial conduct. It is not a single event — the signing of a document — but an ongoing process of communication between the research team and the patient. The informed consent document describes: the purpose of the study and why it is being done; the treatment procedures and schedule; known and potential risks and discomforts; potential benefits (to the patient and to society); alternative treatments available outside the trial; how privacy and confidentiality will be protected; whether any costs are covered; and contact information for…
Understanding Eligibility Criteria
Every clinical trial has specific eligibility criteria — conditions that must be met for a patient to participate. These exist to protect patient safety and ensure that the study generates scientifically valid data. Being excluded from one trial does not mean there are no other options. Inclusion criteria define the characteristics required for participation: specific cancer diagnosis and histology, stage of disease, specific molecular alterations (e.g., EGFR mutation, MSI-H status), prior lines of treatment (e.g., "must have received at least one prior platinum-based regimen"), and…
Costs and Practical Logistics
A common barrier to trial participation is concern about cost. Understanding how costs are structured is essential: Under the Affordable Care Act (ACA), health insurers participating in ACA marketplaces and Medicare are required to cover "routine costs of care" incurred while participating in a qualifying clinical trial. This includes standard tests, hospitalizations, physician visits, and other medical care that would be provided outside of the trial context. The investigational treatment itself is typically provided at no cost by the trial sponsor (pharmaceutical company, NCI, or academic…
How to Find a Trial
Finding the right clinical trial requires a systematic approach: ClinicalTrials.gov is the definitive registry of clinical trials conducted in the US and internationally, maintained by the National Library of Medicine. It contains over 450,000 registered studies. Use this app's Clinical Trials Browser to search by cancer type, phase, location, and recruiting status. NCI Cancer Information Service: Call 1-800-4-CANCER (1-800-422-6237), Monday–Friday, to speak with a trained information specialist who can help search for trials, explain eligibility, and navigate the registration process.…
Questions to Ask Before Enrolling
Before agreeing to participate in a clinical trial, ask the research team the following questions to ensure you are fully informed: About the trial: What is the purpose of this trial and what phase is it? What is the standard treatment I would receive if I don't enroll? What are the potential benefits of participation? What are the known and possible risks? About your specific situation: Have other patients with my diagnosis enrolled, and what were their outcomes? Are there results from earlier phases of this trial that I can review? How does this trial compare to other trials I might be…